Skip to main content
Follow Gene Therapy Net on X LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net
 
Gene Therapy Net Newsletter  
genetherapynetbanner468x60

­

News: Gene Therapy Rapidly Improves Night Vision in Adults with Congenital Blindness

­

Adults with a genetic form of childhood-onset blindness experienced striking recoveries of night vision within days of receiving an experimental gene therapy, according to researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania. The patients had Leber Congenital Amaurosis (LCA), a congenital blindness caused by mutations in the gene GUCY2D 

Read more…

­

­

­

News: Codex DNA's BioXp 9600 System debuting at CAR-TCR Summit

­

Increasing the power of optimized synthetic biology workflows with expanded throughput and scale: Introducing the BioXpTM 9600 System. Codex DNA – a San Diego-based biotechnology company, and pioneer in automated benchtop synthetic biology systems – will be debuting their next-generation fully-automated synthetic biology benchtop workstation, the BioXp 9600 System, at this year’s CAR-TCR summit.

Read more…

­

­

­

Conference: Process Development for Cell Therapies Summit 

­

“The Process is the Product” – Drive Process Excellence at the Only Summit Dedicated to Process Development for Cell Therapies.
As momentum continues to build for the cell therapy industry, process development looms as a huge potential bottleneck to overcome. The inaugural Process Development for Cell Therapies Summit, October 18-20, 2022, will give you unprecedented access to an industry melting pot of process development tools and experience to drive down cost of goods, maximize scalability and achieve regulatory compliance.

Register now…

­

­

­

Conference: Medical Affairs Summit

­

Clinical Trial Executives Representing Americas Pharmaceutical Industries gather on 27-28 October 2022 at an exquisite location the Encore Boston Harbor, Boston, MA, US. The Medical Affairs Summit Summit provides a highly focused and interactive atmosphere to address and gain solutions specific to the core concerns of individual attendees. Through one-on-one business meetings, sponsors get to meet key decision makers.
This is an unparalleled opportunity for extensive informal networking among industry peers during event meals, cocktail receptions and leisure entertainment. 

Register now…

­

­

­

Conference: 4th Annual Gene Therapy Analytical Development

­

Develop, Validate & Implement Cell-Based & Biophysical Analytical Methods to Guarantee Safe, High Quality, Consistent & Efficacious Gene Therapy Products at Scale
The past twelve months have culminated in an unprecedented level of excitement, investment, and clinical progress within the gene therapy field. As the field strives to strike a delicate balance between safety and efficacy, in the context of increased regulatory scrutiny and safety challenges, attending the 4th Annual Gene Therapy Analytical Development, (November 28 - December 1, 2022), as an analytical scientist has never been so important.
This year’s summit returns in-person to Boston to reunite 300+ analytical experts in innovative biotech, pharma, and academia to continue to develop resilient, long-lasting and robust analytical tools to enhance the safety, quality and efficacy of gene therapy products.  

Register now…

­

­

­

Conference: 2nd Rare CNS & Neurodevelopmental Drug Development Summit

­

Join 100+ peers this November at the 2nd Rare CNS & Neurodevelopmental Drug Development Summit (November 28-30, 2022) - the only industry dedicated drug development forum for large pharma, biotech, academia, and patient advocacy groups, paving the way towards symptomatic and successful disease modifying treatments.
Tightly focused on industry progress, stakeholders will explore ASOs, gene therapies and small molecules across autistic syndromes and seizure phenotypes at this unique drug sponsor conference.
Don’t miss out on this definitive opportunity to collaborate with patient groups and gain regulatory clarity on clinical trial design, endpoints and delivery and toxicity concerns as well as deep diving into functional and molecular biomarkers, emerging therapeutic targets and translational biology.
If you are working towards treatments for rare CNS and neurodevelopmental disorders, including (but not limited to) Angelman Syndrome, Rett syndrome, Fragile X, Dravet Syndrome and CDKL5 Syndrome or discovering new frontiers in anti-epileptic therapeutics, this is the platform you need.

Register now…

­

­

­

Conference: 4th Annual Gene Therapy for Neurological Disorders

­

With systemic toxicity challenges plaguing the AAV field, direct administration for CNS indications creates an ideal target for gene therapy. This is an exciting year for the neurological space with clinical data to show and new biotechs coming out of the woodwork to release the next wave of gene therapies with more advanced CNS targeting for a wider selection of neurological targets.
The 4th Annual Gene Therapy for Neurological Disorders Summit, December 5-8, 2022, will unite gene therapy developers with an industry-focused agenda across 4 days and 2 dedicated tracks of content to solve the preclinical, translational and clinical challenges of targeting a wide range of neurodevelopmental and neurodegenerative disorders with both ‘first’ and ‘next’ generation gene therapies.

Register now…

­

­

­

Conference: Cell & Gene Therapy Manufacturing & Commercialization Europe

­

Europe’s cell and gene therapy congress for groundbreaking manufacturing, commercialization & supply chain strategies. Hear from the world-renowned leaders share the latest analytical techniques & vector technologies to revolutionize your cell, gene & gene edited ex vivo cell therapy programs (5-8 December 2022).

Register now…

­

­

­

Conference: 7th Oncolytic Virotherapy Summit 

­

The 7th Oncolytic Virotherapy Summit, December 6-8, 2022, is the only definitive meeting covering clinical development, CMC and manufacturing, partnering and licensing, and route to market. Don’t miss the opportunity to join 100+ OV leaders in Boston including GC Oncology, Amgen, BMS, Boehringer Ingelheim, Astellas and more as we weaponize oncolytic viruses to generate robust antitumor immunity and translate this promising therapeutic into clinical practice to provide real benefits for patients in need.

Register now…

­

­

­

Conference: 6th Annual Cell and Gene Therapy Innovation Summit

­

The 6th Annual Cell and Gene Therapy Innovation Leaders Summit 2023 (15-16 February 2023) is an exclusive and private gathering that focuses on bringing together industry captains, decision-makers and intellectual vanguards across cell and gene therapy to network, learn and advance. This is an in-person only event taking place in Berlin, Germany. Use code GeneTherapyNet to get 20% discount on registration!

Register now…

­

­

­

Upcoming conferences and meetings

­

  • 18 - 19 October 2022 - iPSC-Derived Immunotherapies Congress - Boston, MA
  • 18 - 20 October 2022 - 3rd Annual Gene Therapy Immunogenicity Summit - Boston, MA
  • 18 - 20 October 2022 - Process Development for Cell Therapies Summit - Boston, MA
  • 18 - 20 October 2022 - Innate Killer Summit Europe - London, UK
  • 20 - 21 October 2022 - Reuters Events: Oncology at Total Health 2022 - T-cell therapies - Chicago, USA
  • 24 - 26 October 2022 - 4th TIL Therapies Summit - Boston, MA
  • 24 - 26 October 2022 - 7th annual Neoantigen-Based Therapies Summit 2022 - Boston, MA
  • 25 - 27 October 2022 - 6th Annual Gene Therapy for Rare Disorders Europe Summit 2022 - London, UK
  • 27 - 28 October 2022 - Medical Affairs Summit - Cell and Gene Therapies - Boston, MA
  • 2 – 3 November 2022 - Onco Cell Therapy Summit 2022 - Amsterdam, The Netherlands
  • 7 – 8 November 2022 - 8th Annual Cell & Gene Therapy Manufacturing Congress - London, UK
  • 16 – 17 November 2022 - 3rd Gene and Cell Therapies: CMC, CGT & Vector Manuf. Summit - Vienna & Online
  • 16 – 18 November 2022 - Joint meeting of the Australasian Gene and Cell Therapy Society - Melbourne, Australia
  • 17 – 18 November 2022 - 6th Aseptic Processing Summit - Manufacturing ATMPs and vaccines - Vienna & Online
  • 28 - 30 November 2022 - 2nd Rare CNS & Neurodevelopmental Drug Development Summit - Boston, MA
  • 28 November - 1 December 2022 - 4th Annual Gene Therapy Analytical Development - Boston, MA
  • 5 - 7 December 2022 - Cell Therapy Analytical Development Summit - Boston, MA
  • 5 - 8 December 2022 - Cell & Gene Therapy Manufacturing & Commercialization Europe - Amsterdam & Online
  • 5 - 8 December 2022 - 4th Annual Gene Therapy for Neurological Disorders - Boston, MA
  • 6 - 7 December 2022 - 2nd iPSC-Derived Cell Therapies Summit - Boston, MA
  • 6 - 8 December 2022 - 7th Oncolytic Virotherapy Summit - Boston, MA
  • 24 - 26 January 2023 - 2nd Annual mRNA-Based Therapeutics Summit - Berlin, Germany
  • 30 January - 1 February 2023 - 3rd TGF-β for Immuno-Oncology Drug Development Summit - San Francisco, CA
  • 31 January - 2 February 2023 - Viral Vector Process Development Summit - Boston, MA
  • 15 - 16 February 2023 - 6th Annual Cell & Gene Therapy Innovation Summit - Berlin, Germany
  • 14 - 16 March 2023 - 6th Annual Bioprocessing Summit Europe - Barcelona, Spain
  • 20 - 22 March 2023 - 12th Spring Meeting of the International Society for BioProcess Technology - Norfolk, VA
  • 17 - 19 April 2023 - Advancing Gene Therapy 2023 - Boston, MA
  • 26 - 27 April 2023 - World Oncology Cell Therapy Congress USA - Boston, MA
  • 8 - 10 May 2023 - ISBioTech Nucleic Acids meeting - Production of DNA and RNA Biotherapeutics - Savannah, GA
  • 10 - 12 May 2023 - Bioprocessing Events 2023 - Berlin, Germany
  • 17 - 20 May 2023 - American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting - Los Angeles, CA
  • 24 – 27 October 2023 - Annual Congress of the European Society of Gene and Cell Therapy - Brussels, Belgium

­

Advertise on this site?